Analgesic Effect of Resistance Training for Breast Cancer Survivors
CompletedNot applicableNCT04509284
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Persistent pain after treatment for breast cancer is a major clinical problem, affecting 25-60 % of the patients and is a source of considerable physical disability and psychological distress. Thus, the development of novel interventions to improve pain management for these patients is of clinical importance. Resistance training (RT) is a promising tool to combat a variety of undesirable adverse effects due to breast cancer treatment. Further, research suggests that it may also be able to provide pain-relieving benefits. Hypothesis: Resistance training will improve pain perception and physical function in the short- and long term compared to a non-training control group.
Study details
- Official title
- Effect of Resistance Training of Persistent Pain After Breast Cancer
- Conditions
- Breast Cancer
- Surgery
- Chemotherapy Effect
- Radiotherapy Side Effect
- Pain, Chronic
- Interventions
- Other: Training
- Other: Control
- Sponsor
- Aalborg University
- Collaborators
- Danish Cancer Society; Danish Cancer Survivor and Late Effects Group; Universidad de Granada
- Start date
- 2020-08-10
- Primary completion
- 2021-09-23
- Sex
- Female
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Denmark
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * primary diagnosis of breast cancer (grades I-IIIA). * adult women at least 18 years of age. * having received breast cancer treatment (i.e. surgery and possible adjuvant chemo and/or radiotherapy) at least 18 months before the start of the study. * self reported pain in the areas of the breast, shoulder, axilla, arm and/or side of body with an intensity of ≥ 3 on a numeric rating scale (0 = no pain, 10 = worst pain imaginable). * no signs of cancer recurrence. * reading, writing and speaking Danish. Exclusion Criteria: * breast surgery for cosmetic reasons or prophylactic mastectomy. * bilateral breast cancer. * lymphedema. * other chronic pain conditions (e.g., rheumatoid arthritis). * previous diagnosis of fibromyalgia syndrome.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04509284